David A. Siegel Fulgent Genetics, Inc. Transaction History
Two Sigma Advisers, LP
- $43.8 Billion
- Q2 2024
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Fulgent Genetics, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 24,500 shares of FLGT stock, worth $476,035. This represents 0.0% of its overall portfolio holdings.
Number of Shares
24,500Holding current value
$476,035% of portfolio
0.0%Shares
5 transactions
Others Institutions Holding FLGT
# of Institutions
194Shares Held
15.4MCall Options Held
1.07MPut Options Held
27.9K-
Black Rock Inc. New York, NY3.92MShares$76.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.44MShares$27.9 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.11MShares$21.5 Million0.01% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny959KShares$18.6 Million0.01% of portfolio
-
Park West Asset Management LLC Larkspur, CA833KShares$16.2 Million1.3% of portfolio
About Fulgent Genetics, Inc.
- Ticker FLGT
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 30,265,800
- Market Cap $588M
- Description
- Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...